China National Accord Medicines Corporation Ltd.
China National Accord Medicines Corporation Ltd. (CNAM) is a prominent player in the pharmaceutical industry, headquartered in China. Established in 1997, the company has made significant strides in the development, production, and distribution of a wide range of pharmaceutical products, including traditional Chinese medicines and modern pharmaceuticals.
With a strong operational presence across various regions in China, CNAM is dedicated to enhancing healthcare through innovative solutions. The company is recognised for its commitment to quality and efficacy, offering unique formulations that cater to diverse medical needs.
As a leader in the sector, CNAM has achieved notable milestones, including numerous certifications and awards that underscore its market position. With a focus on research and development, CNAM continues to contribute to the advancement of healthcare in China and beyond.
-3 vs industry average
China National Accord Medicines Corporation Ltd.’s score of 31 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at China National Accord Medicines Corporation Ltd.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Retail Trade Services has below-average carbon intensity
Industry performance
The Retail Trade Services industry has reduced its overall emissions by 31% since 2018
Reported emissions
No reported emissions data is available for China National Accord Medicines Corporation Ltd. yet.
China National Accord Medicines Corporation Ltd.'s reported carbon emissions
China National Accord Medicines Corporation Ltd., headquartered in CN, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sinopharm Group Co. Ltd., which may influence its climate commitments and performance metrics.
As of now, there are no documented reduction targets or climate pledges from China National Accord Medicines Corporation Ltd. This lack of specific initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
Given the absence of emissions data and reduction initiatives, it is essential for the company to establish clear climate commitments and targets to align with industry standards and expectations. This would not only enhance their sustainability profile but also contribute positively to the broader efforts in mitigating climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
China National Accord Medicines Corporation Ltd.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for China National Accord Medicines Corporation Ltd. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
China National Accord Medicines Corporation Ltd.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project